Prosecution Insights
Prosecution Insights
48 pending office actions • 31 clients • 47 examiners • 32 art units • 0 of 48 (0%) have an AI response strategy ready • 62 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 21 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 21 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §103 only | 26 (54%) |
| §102 only | 4 (8%) |
| §112 only | 6 (12%) |
| Double-patenting only | 6 (12%) |
| Double-patenting + other | 1 (2%) |
| No statute on record | 4 (8%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ANDERSON, REBECCA L | 2 | 73.4% | +23.7% |
| BECKHARDT, LYNDSEY MARIE | 1 | 27.9% | +48.2% |
| MINSKEY, JACOB T | 1 | 68.8% | +33.5% |
| MEADE, LORNE EDWARD | 1 | 50.8% | +39.5% |
| VALENROD, YEVGENY | 1 | 72.5% | +25.5% |
| SWIFT, CANDICE LEE | 1 | 56.2% | +36.6% |
| HIBSHMAN, SARAH GRACE | 1 | 39.6% | +43.0% |
| YOO, SUN JAE | 1 | 71.1% | +0.0% |
| SINGH, SATYENDRA K | 1 | 60.9% | +67.3% |
| MARTIN, RACHEL E | 1 | 54.4% | +57.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18999039 | Surfactant Formulations for Inhalation | BECKHARDT, LYNDSEY MARIE | 66d overdue |
| 18032023 | A Purified Extract Isolated from Agrimonia Coreana Nakai Containing Abundant Amount of Active Ingredient, the Preparation Thereof, the Composition Comprising the Same as an Active Ingredient for Preventing or Treating Inflammation, Allergy and Atopic Dermatitis and the Use Thereof | MOREAU, NASHARA LOUISE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18999039 | Surfactant Formulations for Inhalation | BECKHARDT, LYNDSEY MARIE | 66d overdue |
| 18422936 | Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics | HIBSHMAN, SARAH GRACE | 37d overdue |
| 18413954 | Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals | SINGH, SATYENDRA K | 12d |
| 18838957 | A Bleaching Process | MINSKEY, JACOB T | — |
| 18804359 | Engine Systems and Uses Thereof | MEADE, LORNE EDWARD | — |
| 18782372 | Pharmaceutical Compounds And Compositions As c-Kit Kinase Inhibitors | VALENROD, YEVGENY | — |
| 18659478 | Compositions and Methods for Modulating the Intestinal Microbiome | SWIFT, CANDICE LEE | — |
| 18578921 | Phytase Variants | MARTIN, RACHEL E | — |
| Art Unit | Apps |
|---|---|
| 1657 | 4 |
| 1693 | 3 |
| 1613 | 2 |
| 1627 | 2 |
| 1652 | 2 |
| 1615 | 2 |
| 1626 | 2 |
| 1732 | 2 |
| 1629 | 2 |
| 1643 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18999039 | Surfactant Formulations for Inhalation | Merz Pharmaceuticals, LLC | BECKHARDT, LYNDSEY MARIE | 1613 | §103 | Final Rejection | 66d overdue | Pending | Dec 23, 2024 |
| 18838957 | A Bleaching Process | AB Enzymes GmbH | MINSKEY, JACOB T | 1748 | §103 | Final Rejection | — | Pending | Aug 15, 2024 |
| 18804359 | Engine Systems and Uses Thereof | Alpha Portfollo LLC | MEADE, LORNE EDWARD | 3741 | §112 | Final Rejection | — | Pending | Aug 14, 2024 |
| 18782372 | Pharmaceutical Compounds And Compositions As c-Kit Kinase Inhibitors | Enanta Pharmaceuticals, Inc. | VALENROD, YEVGENY | §112 | Non-Final OA | — | Pending | Jul 24, 2024 | |
| 18659478 | Compositions and Methods for Modulating the Intestinal Microbiome | Gelesis, LLC | SWIFT, CANDICE LEE | 1657 | DP | Non-Final OA | — | Pending | May 09, 2024 |
| 18422936 | Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics | Glycologix, Inc. | HIBSHMAN, SARAH GRACE | 1693 | §103 | Final Rejection | 37d overdue | Pending | Jan 25, 2024 |
| 18420855 | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | Enanta Pharmaceuticals, Inc. | YOO, SUN JAE | 1621 | DPOther | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18413954 | Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals | Ramon Gonzalez | SINGH, SATYENDRA K | 1657 | §112 | Non-Final OA | 12d | Pending | Jan 16, 2024 |
| 18578921 | Phytase Variants | AB Enzymes OY | MARTIN, RACHEL E | 1657 | §112 | Final Rejection | — | Pending | Jan 12, 2024 |
| 18578970 | Phytase Variants with Improved Stability and IP4 Activity | AB Enzymes OY | RAGHU, GANAPATHIRAM | 1699 | DP | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18569713 | Complexes Of CU(I) As Antitumor Agents | UNIVERSITA DEGLI STUDI DI PADOVA | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18387577 | Use Of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline For Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease | Rottapharm Biotech S.r.l. | BARSKY, JARED | 1628 | §103 | Non-Final OA | 36d overdue | Pending | Nov 07, 2023 |
| 18379685 | METHODS AND COMPOSITIONS FOR TREATING LONG COVID-19 | Intrinsic Medicine, Inc. | KRISHNAN, GANAPATHY | 1693 | §103 | Non-Final OA | 4d overdue | Pending | Oct 13, 2023 |
| 18480009 | USE AND DETECTION METHOD OF FLAVIVIRUS PROTEIN MICROARRAY | National Cheng Kung University | CHESTNUT, BARRY A | 1672 | §103 | Non-Final OA | 28d | Pending | Oct 03, 2023 |
| 18454013 | PEPTIDES AND METHODS OF USING THE SAME | Serpin Pharma, LLC | FISCHER, JOSEPH | 1658 | DP | Non-Final OA | — | Pending | Aug 22, 2023 |
| 18236560 | FUSED HETEROBICYCLIC ANTIVIRAL AGENTS | Enanta Pharmaceuticals, Inc. | REILLY, SOPHIA JANE | 1627 | Other | Non-Final OA | 5d | Pending | Aug 22, 2023 |
| 18327321 | ITERATIVE PLATFORM FOR THE SYNTHESIS OF ALPHA FUNCTIONALIZED PRODUCTS | Ramon Gonzalez | HUTSON, RICHARD G | 1652 | DP | Non-Final OA | — | Pending | Jun 01, 2023 |
| 18038501 | SOLIDIFIED LIP GLOSS STICK-TYPE COSMETIC COMPOSITION STABILIZING HIGH-CONTENT OLIGOMER-TYPE PHYTOSTEROL ESTERS | C&C International Co., Ltd. | AL-AWADI, DANAH J | 1615 | §103 | Final Rejection | — | Pending | May 24, 2023 |
| 18253712 | METHODS AND COMPOSITION FOR KRAS MODIFICATIONS | Dunad Therapeutics Ltd. | ANDERSON, REBECCA L | 1626 | §102 | Non-Final OA | — | Pending | May 19, 2023 |
| 18196092 | COMPOUND, A CONJUGATE AND USES THEREOF | Synerk Inc. | BERRY, LAYLA D | 1693 | §102 | Final Rejection | — | Pending | May 11, 2023 |
| 18035623 | PHOTOSTABLE COMPOSITION | Ndg Natural Development Group S.r.l. | BROWE, DAVID | 1617 | §103 | Final Rejection | — | Pending | May 05, 2023 |
| 18139506 | PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS | Enanta Pharmaceuticals, Inc. | ANDERSON, REBECCA L | 1626 | §103 | Final Rejection | — | Pending | Apr 26, 2023 |
| 18032023 | A Purified Extract Isolated from Agrimonia Coreana Nakai Containing Abundant Amount of Active Ingredient, the Preparation Thereof, the Composition Comprising the Same as an Active Ingredient for Preventing or Treating Inflammation, Allergy and Atopic Dermatitis and the Use Thereof | Yuran Nam | MOREAU, NASHARA LOUISE | 1655 | §101 | Final Rejection | — | Pending | Apr 14, 2023 |
| 18113685 | RARE EARTH METAL INSTANTIATION | Quantum Elements Development Inc. | GREGORIO, GUINEVER S | 1732 | §103 | Final Rejection | — | Pending | Feb 24, 2023 |
| 18019715 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DYSREGULATION | Response Ip Holding Company, LLC | SEITZ, ANTHONY JOSEPH | 1629 | §103 | Non-Final OA | 27d | Pending | Feb 03, 2023 |
| 18161405 | ANTI-TM4SF1 ANTIBODY-DRUG CONJUGATES COMPRISING CLEAVABLE LINKERS AND METHODS OF USING SAME | Angiex, Inc. | VAN DRUFF, SYDNEY | 1643 | §102 | Final Rejection | — | Pending | Jan 30, 2023 |
| 18102254 | METHOD FOR REMOVING ACIDS FROM ORGANIC SOLVENTS | Nanoscale Components, Inc. | KOLTONOW, ANDREW ROBERT | 1795 | §103 | Non-Final OA | 50d overdue | Pending | Jan 27, 2023 |
| 18148942 | SERPIN PEPTIDES AND METHODS OF USING THE SAME | Serpin Pharma, LLC | DEVI, SARVAMANGALA | 1645 | — | Final Rejection | — | Pending | Dec 30, 2022 |
| 18081431 | AGRICULTURAL COMPOSITIONS COMPRISING MICROBIAL CONSORTIA, AND METHODS OF USE THEREOF | Microbes, Inc. | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | 9d overdue | Pending | Dec 14, 2022 |
| 18080114 | Systems And Methods For Carbon Dioxide Conversion | Carbogenesis LLC | TAI, XIUYU | 1795 | §103 | Non-Final OA | — | Pending | Dec 13, 2022 |
| 18080023 | Systems and Methods for Nitrogen Fixation | Soane Technologies, LLC | LI, JUN | 1732 | §103 | Non-Final OA | 16d overdue | Pending | Dec 13, 2022 |
| 17989103 | SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | Enanta Pharmaceuticals, Inc. | MOORE, SUSANNA | 1624 | §103 | Non-Final OA | 9d overdue | Pending | Nov 17, 2022 |
| 17981620 | Methods and Compositions for Weight Management and for Improving Glycemic Control | Gelesis, LLC | LI, CHANGQING | 1791 | §103 | Non-Final OA | 63d | Pending | Nov 07, 2022 |
| 18051573 | ANTI-TM4SF1 ANTIBODY DRUG CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. | SKOKO III, JOHN JOSEPH | 1643 | §102 | Non-Final OA | — | Pending | Nov 01, 2022 |
| 17951891 | PHASED INTRODUCTION OF LITHIUM INTO THE PRE-LITHIATED ANODE OF A LITHIUM ION ELECTROCHEMICAL CELL | Nanoscale Components, Inc. | CHAN, HENG M | 1725 | Other | Non-Final OA | 26d | Pending | Sep 23, 2022 |
| 17892436 | SURFACTANT FORMULATIONS FOR INHALATION | Merz Pharmaceuticals, LLC | HELM, CARALYNNE E | 1615 | §103 | Final Rejection | 98d overdue | Pending | Aug 22, 2022 |
| 17796904 | XANTHAN-BASED OPHTHALMIC TOPICAL FORMULATIONS WITH A REDUCED DOSAGE REGIMEN | Sifi S.p.A. | CREWS, JARET JAMES | 1691 | §103 | Final Rejection | 119d overdue | Pending | Aug 02, 2022 |
| 17781168 | METHOD FOR THE DETERMINATION OF SODIUM HYALURONATE CONTENT IN A HYDROGEL | UB-CARE S.R.L. | SIMMONS, VALERIE MICHELLE | 1758 | §103 | Final Rejection | 13d | Pending | May 31, 2022 |
| 17697081 | COMPOUNDS AND METHODS USEFUL FOR MODULATING GENE SPLICING | Arnay Sciences, LLC | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | — | Pending | Mar 17, 2022 |
| 17584663 | RAPID RELIEF OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE | Merz Pharmaceuticals, LLC | HASTINGS, ALISON AZAR | 1627 | DP | Non-Final OA | 78d overdue | Pending | Jan 26, 2022 |
| 17623331 | APPLICATION OF PROGESTIN IN PREPARATION OF DRUG INHIBITING CYTOKINE STORM | Shenzhen Evergreen Therapeutics Co., Ltd. | DAHLIN, HEATHER RAQUEL | 1629 | §103 | Final Rejection | 20d | Pending | Dec 28, 2021 |
| 17622697 | Improved Mannanase Variants | AB Enzymes OY | ZINGARELLI, SANDRA | 1653 | §112 | Non-Final OA | — | Pending | Dec 23, 2021 |
| 17610979 | AEROGEL- AND/OR XEROGEL-BASED MASS FOR ADVANCED MANUFACTURING AND USE THEREOF | ETH ZÜRICH | VO, HAI | 1788 | §103 | Final Rejection | — | Pending | Nov 12, 2021 |
| 17501142 | Compositions and Methods for Treating or Preventing Gut Permeability-Related Disorders | Gelesis LLC | SONG, JIANFENG | 1613 | Other | Non-Final OA | 17d overdue | Pending | Oct 14, 2021 |
| 17601741 | Solution Stable Enzyme Composition | AB Enzymes OY | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | — | Pending | Oct 06, 2021 |
| 17478293 | ANTISENSE OLIGONUCLEOTIDES FOR ALLELE SPECIFICITY | Arnay Sciences LLC | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Final Rejection | 73d overdue | Pending | Sep 17, 2021 |
| 17291125 | Fusion Protein | AB Enzymes OY | BREEN, KIMBERLY CATHERINE | 1657 | DP | Non-Final OA | — | Pending | May 04, 2021 |
| 16755370 | METHOD FOR SELECTING HIGHLY EFFICIENT STEM CELL, USING PROTEIN MARKER GRP78 | Seoul National University R&Db Foundation | SZPERKA, MICHAEL EDWARD | 1641 | §103 | Non-Final OA | — | Pending | Apr 10, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial